Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sanofi symbols : BLUE save search
Global Gene Therapy Market Research Report 2022-2031 Featuring Major Players - Novartis AG; Bluebird bio, Inc.; Spark Therapeutics, Inc; Audentes Therapeutics; Voyager Therapeutics
Published: 2022-06-20 (Crawled : 12:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
| Email alert
Add to watchlist
CLLS | $2.47 0.4% 12K
|
Health Technology
| Email alert
Add to watchlist
SRPT | $115.53 -0.88% -0.9% 640K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
| Email alert
Add to watchlist
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
research report novartis therapeutics therapy market
Global Gene Therapy Markets Report 2021-2030: Antigen, Cytokine, Suicide Gene, Viral Vector, Non-Viral Vector, Oncological, Rare Diseases, Cardiovascular, Neurological Disorders, Infectious Diseases
Published: 2021-06-25 (Crawled : 11:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.16%
H: 0.09%
C: -0.13%
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: 0.73%
H: 2.08%
C: 2.01%
SRPT | $115.53 -0.88% -0.9% 640K
|
Health Technology
|
| O: 0.15%
H: 1.37%
C: 0.75%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
CLLS | $2.47 0.4% 12K
|
Health Technology
|
| O: -0.45%
H: 1.88%
C: 1.3%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: -4.89%
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -1.97%
H: 0.24%
C: -2.72%
disease neurological cardiovascular infectious disease gene therapy therapy cardio gene therapies rare
BioSpace Movers & Shakers, May 21
Published: 2021-05-21 (Crawled : 15:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.24%
C: 0.0%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.52%
H: 1.19%
C: -0.07%
XERS | $1.73 -1.7% -1.73% 2M
|
Health Technology
|
| O: 1.71%
H: 0.61%
C: -2.53%
TELA | $4.76 -7.57% -8.19% 120K
|
Health Technology
|
| O: 1.36%
H: 4.17%
C: -1.41%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 2.21%
H: 0.0%
C: -0.46%
IART | $28.68 -9.33% -10.29% 2.9M
|
Health Technology
|
| O: -0.32%
H: 1.67%
C: -0.61%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: 0.98%
H: 2.74%
C: 1.71%
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: 0.77%
H: 3.05%
C: 0.38%
space spac
AavantiBio Rounds Out Leadership Team with Appointment of Jessie Hanrahan, Ph.D. as Chief Regulatory Officer
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: -0.12%
H: 0.77%
C: 0.53%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: -1.06%
H: 2.33%
C: -0.3%
IBIO | $1.72 -2.83% 0.0% 95K
|
Health Technology
|
| O: -7.48%
H: 6.44%
C: 0.0%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.